tiprankstipranks
Trevena Inc (DE:6T4)
BERLIN:6T4

Trevena Stock Analysis & Ratings

0 Followers

6T4 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.18 - €1.40
Previous Close€0.22
Volume0.00
Average Volume (3M)3.67K
Market CapN/A
Enterprise ValueN/A
P/E RatioN/A
Beta-0.19
Next EarningsNov 09, 2022
EPS Forecast-€0.08
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)N/A
Shares Outstanding165,520,007
R-Squared0.09
Standard Deviation0.19
10 Day Avg. Volume60
30 Day Avg. Volume3,667
P/B Ratio0.88
P/S Ratio1725.55
P/CF RatioN/A
P/FCF Ratio-1.00
Total Debt€6.78M
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside685.96% Upside
Rating ConsensusModerate Buy
Alpha-0.06
Number of Analyst Covering2


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

6T4 FAQ

What was Trevena’s price range in the past 12 months?
Trevena lowest stock price was €0.18 and its highest was €1.40 in the past 12 months.
    What is Trevena’s market cap?
    Currently, no data Available
    What is Trevena’s price target?
    The average price target for Trevena is €1.74. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is €1.99 ,the lowest forecast is €1.49. The average price target represents 685.96% Increase from the current price of €0.221.
      What do analysts say about Trevena?
      Trevena’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
        When is Trevena’s upcoming earnings report date?
        Trevena’s upcoming earnings report date is Nov 09, 2022 which is in 82 days.
          How were Trevena’s earnings last quarter?
          Trevena released its earnings results on Aug 11, 2022. The company reported -€0.089 earnings per share for the quarter, beating the consensus estimate of -€0.101 by €0.012.
            Is Trevena overvalued?
            According to Wall Street analysts Trevena’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Trevena pay dividends?
              Trevena does not currently pay dividends.
              What is Trevena’s EPS estimate?
              Trevena’s EPS estimate is -€0.08.
                How many shares outstanding does Trevena have?
                Currently, no data Available
                What happened to Trevena’s price movement after its last earnings report?
                Trevena reported an EPS of -€0.089 in its last earnings report, beating expectations of -€0.101. Following the earnings report the stock price went up 13.861%.
                  Which hedge fund is a major shareholder of Trevena?
                  Among the largest hedge funds holding Trevena’s share is Moore Capital Management LP. It holds Trevena’s shares valued at N/A.

                    ---

                    Trevena Stock Analysis

                    Smart ScoreNeutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    6

                    Analyst Forecast

                    Moderate Buy
                    Average Price Target: €1.74

                    Blogger Sentiment

                    Bullish
                    DE:6T4 Sentiment 100% Sector Average 70%

                    Insider Transactions

                    ▼ Sold Shares
                    Worth $13.0K over the Last 3 Months

                    News Sentiment

                    Positive
                    Bullish 100% Bearish 0%

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -80.75%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    -93.45%
                    Trailing 12-Months
                    Asset Growth
                    -42.22%
                    Trailing 12-Months
                    The Trevena Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Trevena Inc

                    Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    AbbVie
                    Amgen
                    Gilead Sciences
                    Moderna
                    Vertex Pharmaceuticals

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis